Main
>
ONCOLOGY (**)
>
Brain Cancer>GBM>Recurrent (R) *
>
Treatment
>
USA. G. BevacizuMAb
>
(*) USA Approval Date: 2017. 12.05.
(*) USA Approval Date: 2017. 12.05.'s products
This section has no products